These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 11559435)

  • 1. Oromucosal interferon therapy: relationship between antiviral activity and viral load.
    Schellekens H; Geelen G; Meritet JF; Maury C; Tovey MG
    J Interferon Cytokine Res; 2001 Aug; 21(8):575-81. PubMed ID: 11559435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of orally/sublingually, intranasally, and intraperitoneally administered recombinant murine interferon in the treatment of murine encephalomyocarditis virus.
    Sonnenfeld G; Tovey M; Schellekens H; Kinney KS; Belay T; Morton DS; Austin CE; Reitman M; Fong TA; Vaughan HS
    J Interferon Cytokine Res; 2001 Jul; 21(7):539-45. PubMed ID: 11506749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oromucosal interferon therapy: marked antiviral and antitumor activity.
    Tovey MG; Maury C
    J Interferon Cytokine Res; 1999 Feb; 19(2):145-55. PubMed ID: 10090400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic effects of tacrolimus and human interferon-alpha A/D in murine viral myocarditis.
    Kanda T; Nagaoka H; Kaneko K; Wilson JE; McManus BM; Imai S; Suzuki T; Murata K; Kobayashi I
    J Pharmacol Exp Ther; 1995 Jul; 274(1):487-93. PubMed ID: 7542339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of oromucosal administration of IFN-alpha on allergic sensitization and the hypersensitive inflammatory response in animals sensitized to ragweed pollen.
    Meritet JF; Maury C; Tovey MG
    J Interferon Cytokine Res; 2001 Aug; 21(8):583-93. PubMed ID: 11559436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oromucosal interferon therapy: pharmacokinetics and pharmacodynamics.
    Eid P; Meritet JF; Maury C; Lasfar A; Weill D; Tovey MG
    J Interferon Cytokine Res; 1999 Feb; 19(2):157-69. PubMed ID: 10090401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumol inhibits encephalomyocarditis virus by promoting IFN-β secretion.
    Zheng J; Xu Y; Khan A; Sun P; Sun Y; Fan K; Yin W; Wang S; Li H; Sun N
    BMC Vet Res; 2021 Sep; 17(1):318. PubMed ID: 34587973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of intranasal administration of recombinant murine interferon-gamma on murine acute myocarditis caused by encephalomyocarditis virus.
    Yamamoto N; Shibamori M; Ogura M; Seko Y; Kikuchi M
    Circulation; 1998 Mar; 97(10):1017-23. PubMed ID: 9529271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of invariant NKT cells in lipopolysaccharide-induced lethal shock during encephalomyocarditis virus infection.
    Ando T; Ito H; Ohtaki H; Kanbe A; Hirata A; Hara A; Seishima M
    Immunobiology; 2017 Feb; 222(2):350-357. PubMed ID: 27665995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosal cytokine therapy: marked antiviral and antitumor activity.
    Tovey MG; Meritet JF; Guymarho J; Maury C
    J Interferon Cytokine Res; 1999 Aug; 19(8):911-21. PubMed ID: 10476938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oromucosal cytokine therapy: mechanism(s) of action.
    Tovey MG
    Taehan Kan Hakhoe Chi; 2002 Jun; 8(2):125-31. PubMed ID: 12499797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of tolerance to recombinant therapeutic proteins.
    Meritet JF; Maury C; Tovey MG
    J Interferon Cytokine Res; 2001 Dec; 21(12):1031-8. PubMed ID: 11798460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of OK432 and human interferon-alpha for treating viral-induced diabetes mellitus in mice.
    Kanda T; Kogure S; Nara M; Tsukui S; Utsugi T; Tomono S; Kawazu S; Nagai R; Kobayashi I
    Eur J Pharmacol; 1998 Jan; 342(2-3):297-302. PubMed ID: 9548400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral profile of Nyctanthes arbortristis L. against encephalitis causing viruses.
    Gupta P; Bajpai SK; Chandra K; Singh KL; Tandon JS
    Indian J Exp Biol; 2005 Dec; 43(12):1156-60. PubMed ID: 16359127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective role of interleukin-12 in viral myocarditis.
    Shioi T; Matsumori A; Nishio R; Ono K; Kakio T; Sasayama S
    J Mol Cell Cardiol; 1997 Sep; 29(9):2327-34. PubMed ID: 9299356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective efficacy of adenovirus-mediated small interfering RNAs against encephalomyocarditis virus challenge in mice.
    Bai J; Jiang K; Zhang L; Wang X; Wang X; Li Y; Jiang P
    J Virol Methods; 2012 Nov; 185(2):204-12. PubMed ID: 22790206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo antiviral activity of recombinant murine gamma interferon.
    Shalaby MR; Hamilton EB; Benninger AH; Marafino BJ
    J Interferon Res; 1985; 5(2):339-45. PubMed ID: 2989389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of low-dose oral use of type I interferon in cytomegalovirus infections in vivo.
    Bosio E; Beilharz MW; Watson MW; Lawson CM
    J Interferon Cytokine Res; 1999 Aug; 19(8):869-76. PubMed ID: 10476931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of lethal respiratory vaccinia infections in mice with interferon-alpha and interferon-gamma.
    Liu G; Zhai Q; Schaffner DJ; Wu A; Yohannes A; Robinson TM; Maland M; Wells J; Voss TG; Bailey C; Alibek K
    FEMS Immunol Med Microbiol; 2004 Apr; 40(3):201-6. PubMed ID: 15039095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of trehalose dimycolate-induced interferon-alpha/beta in the restriction of encephalomyocarditis virus growth in vivo and in peritoneal macrophage cultures.
    Guillemard E; Geniteau-Legendre M; Kergot R; Lemaire G; Petit JF; Labarre C; Quero AM
    Antiviral Res; 1995 Oct; 28(2):175-89. PubMed ID: 8585770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.